Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CDH1 is a classical cadherin from the cadherin superfamily. Additionally we are shipping E-cadherin Kits (77) and E-cadherin Proteins (39) and many more products for this protein.
Showing 10 out of 791 products:
Human Polyclonal E-cadherin Primary Antibody for EIA, WB - ABIN4620543
Mansouri, Spurr, Goodfellow, Kemler: Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. in Differentiation; research in biological diversity 1988
Show all 3 references for ABIN4620543
Human Monoclonal E-cadherin Primary Antibody for ELISA, WB - ABIN969037
Barrett, Lee, Lees, Prescott, Anderson, Phillips, Wesley, Parnell, Zhang, Drummond, Nimmo, Massey, Blaszczyk, Elliott, Cotterill, Dallal, Lobo, Mowat, Sanderson, Jewell, Newman, Edwards, Ahmad et al.: Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. ... in Nature genetics 2009
Show all 3 references for ABIN969037
Human Monoclonal E-cadherin Primary Antibody for FACS, IHC - ABIN969036
Wang, Yao, Zhang, Zhang, Zhao: [Expression and significance of CD147 and E-cadherin in human gastric carcinoma]. in Zhonghua zhong liu za zhi [Chinese journal of oncology] 2009
Show all 3 references for ABIN969036
Human Polyclonal E-cadherin Primary Antibody for FACS, IF (cc) - ABIN1387847
Chen, Cheng, Chen, Sue, Liu, Cheng, Hsu, Chen: MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis. in PLoS ONE 2014
Show all 3 references for ABIN1387847
Human Polyclonal E-cadherin Primary Antibody for FACS, WB - ABIN388278
Hsu, Chen, Chou, Tang, Chen, Wilkins, Ellory, Shen: KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. in Cancer research 2007
Show all 3 references for ABIN388278
Human Monoclonal E-cadherin Primary Antibody for IHC (p) - ABIN180686
Bukholm, Nesland, Børresen-Dale: Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. in The Journal of pathology 2000
Show all 3 references for ABIN180686
Human Polyclonal E-cadherin Primary Antibody for EIA, WB - ABIN4620544
Knudsen, Wheelock: Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. in The Journal of cell biology 1992
Show all 2 references for ABIN4620544
Human Monoclonal E-cadherin Primary Antibody for IHC (fro), IF - ABIN1106274
Umbas, Schalken, Aalders, Carter, Karthaus, Schaafsma, Debruyne, Isaacs: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. in Cancer research 1992
Show all 2 references for ABIN1106274
Cow (Bovine) Polyclonal E-cadherin Primary Antibody for IF, IHC - ABIN2784498
Onder, Gupta, Mani, Yang, Lander, Weinberg: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. in Cancer research 2008
E-cadherin has a role in cranial neural crest migration in Xenopus laevis
the switch from E- to N-cadherin (show CDH2 Antibodies) during epithelial-mesenchymal transition is essential for acquisition of Contact inhibition of locomotion behavior.
Moderate attenuation of C-cadherin function affects cell adhesion but not gastrulation.
Because paraxial protocadherin and C-cadherin do not directly interact nor form a joint complex with Fz7, Wnt-11 triggers formation of two distinct complexes that act in parallel to reduce cell adhesion by hampering clustering of C-cadherin.
The functional and physical relationships between PAPC, FLRT3, and C-cadherin, was investigated.
PAPC mediates these functions by down-regulating the adhesion activity of C-cadherin.
Results suggest that the basis for cell segregation during morphogenesis does not map exclusively to protein-level differences in E-, N-, or C-cadherin adhesion.
G-protein-coupled receptors control cortical actin assembly by controlling the amount of cadherin expressed on the cell surface.
Two stage cadherin kinetics require multiple extracellular domains but not the cytoplasmic region
Data show that the intracellular domain of PAPC (Protocadherin) interacts with Sprouty (Spry), and upon binding to PAPC, Spry function is inhibited and PCP signaling is enhanced.
These observations suggest that the overexpression of CatE (show CTSE Antibodies) interferes with neuronal differentiation of P19 (show CDKN2D Antibodies) cells through an impairment of cell aggregate formation, possibly through proteolytic degradation of N-cadherin (show CDH2 Antibodies).
E-cadherin-mediated cell-cell contacts can modulate osteoclast-specific gene expression and prompt differentiating osteoclast precursors toward migratory and fusion activities.
These results provide a new mechanism by which LXA4 inhibits LPS (show TLR4 Antibodies)-induced ALI through Nrf2 (show NFE2L2 Antibodies)-mediated E-cadherin expression
Demonstrate that HBx-HCCR-E-cadherin regulation pathway might play an important role in HBV-induced hepatocarcinogenesis.
E-cadherin expression regulates inflammatory mediators in macrophages.
Increased expression of E-cadherin binds to and sequesters beta-catenin (show CTNNB1 Antibodies) away from downstream Wnt (show WNT2 Antibodies) signaling proteins.
Results suggest a regulatory function of E-cadherin that modulates Nrg1 (show NRG1 Antibodies) signaling and promotes Schwann cell myelin formation
Both catalytic and non-catalytic APC (show APC Antibodies)/C-Fzr1/Cdh1 (show FZR1 Antibodies)-mediated activities of PTEN (show PTEN Antibodies) are required for stalk cells' proliferative arrest. Findings implicate the PTEN (show PTEN Antibodies)-APC (show APC Antibodies)/C-Fzr1/Cdh1 (show FZR1 Antibodies) hub in angiogenesis.
we conclude that APC (show APC Antibodies)/C(Cdh1) controls CK1 (show KRT1 Antibodies) delta levels to balance proliferation and cell-cycle exit in the developing CNS
During submandibular gland development, a Hippo pathway effector, TAZ (show TAZ Antibodies), becomes increasingly phosphorylated and associated with E-cadherin and alpha-catenin (show CTNNA1 Antibodies), consistent with the activation of Hippo signaling. (Hippo)
The CDH1 -160C/A polymorphism does not seem to significantly influence the expression of E-cadherin in PA and ACC of salivary glands.
DNA methylation (show HELLS Antibodies) level was negatively correlated with mRNA expression of the E-Cadherin gene. Methylation in tumor tissues was significantly higher than that in tumor adjacent tissues (P < 0.05).
Immunostaining allowed the identification of specific cell types with E-cadherin, p53 (show TP53 Antibodies), and inhibin-alpha (show INHA Antibodies) expression in all cases.
CDH1 -160C/A polymorphism is associated with breast cancer.
Bmi-1 (show BMI1 Antibodies) promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
The CDH1 downregulation acted as an independent prognostic biomarker in cytogenetically normal acute myeloid leukemia (show BCL11A Antibodies) (CN-AML (show RUNX1 Antibodies)) patients.
Our study demonstrates that the CDH1 polymorphisms were significantly associated with the risk of nonsyndromic cleft lip with or without cleft palate in the northern Chinese Han population
Low expression of CDH1 is associated with invasion in non-small cell lung cancer.
Low expression of E-cadherin is associated with bladder cancer.
we concluded that the CDH1 -472delA and -160C>A polymorphisms are not associated with diffuse (DGC (show GGCX Antibodies)) or intestinal (IGC) types of gastric cancer in patients from western Mexico.
E-cadherin mRNA/protein were up-regulated in all flutamide-treated corpus luteum of mid- and late pregnancy.
In pig kidney, strong E-cadherin expression was observed in the basolateral plasma membrane of the tubular epithelial cells. E-cadherin immunolabeling was not detected in glomeruli or blood vessels of pig kidney.
Localisation of NANOG (show NANOG Antibodies), OCT4 (show POU5F1 Antibodies), and E-CADHERIN in porcine pre- and peri (show PLIN1 Antibodies)-implantation embryos.
The epiblast expressed epithelial markers, MUC1 (show MUC1 Antibodies) and E-CADHERIN, and the pluripotency markers, DNMT3B (show DNMT3B Antibodies) and CRIPTO (show TDGF1 Antibodies).
Transfection of zygotes with 100 and 200 nM E-cadherin siRNA led to a 72 and 38% reduction, respectively, in E-cadherin mRNA relative abundance in Day 7 blastocysts compared with controls.
E-cadherin and beta-catenin (show CTNNB1 Antibodies) were distributed not only at the cell to cell boundary but throughout the cytoplasm in binucleate trophoblast cells
Results describe the effect of suppression of connexin 43 (show GJA1 Antibodies) and E-cadherin on the development, mRNA and protein expression of bovine blastocysts cultured in vitro or in vivo.
E-cadherin mRNA coinjection demonstrated the specificity of cdh1 morpholino oligonucleotides-induced defects
Results suggest that Wnt11 (show WNT11 Antibodies) controls tissue morphogenesis by modulating E-cadherin-mediated cell cohesion through Rab5c (show Rab5c Antibodies), a novel mechanism of Wnt (show WNT2 Antibodies) signaling in gastrulation.
This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites.
, cadherin 1, type 1, E-cadherin (epithelial)
, epithelial cadherin
, CAM 120/80
, cadherin 1, E-cadherin (epithelial)
, calcium-dependent adhesion protein, epithelial
, cell-CAM 120/80
, liver cell adhesion molecule
, liver cell adhesion protein
, Epithelial cadherin
, hypothetical protein LOC368517